Diseases /
Malignant Intestinal Neoplasm
Back to Diseases List
Associated Genetic Biomarkers
Overview
NCI Definition: A primary or metastatic malignant neoplasm involving the small intestine, large intestine, or both. Representative examples are carcinomas, lymphomas, and sarcomas. [1]
Malignant intestinal neoplasms most frequently harbor alterations in TP53, APC, KRAS, PIK3CA, and SMAD4 [2].
APC Mutation, TP53 Mutation, TP53 Missense, TP53 c.217-c.1178 Missense, and KRAS Mutation are the most common alterations in malignant intestinal neoplasm [2].
Clinical Trials
Significant Genes in Malignant Intestinal Neoplasm
Disease Details
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.
3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.